Basilea Announces Completion Of Toctino Transaction With Stiefel - Quick Facts

7/23/2012 1:38 AM ET

Basilea Pharmaceutica Ltd. (BPMUF.PK) said the transaction between Basilea Pharmaceutica International Ltd. and Stiefel, a GlaxoSmithKline(GSK: Quote,GSK.L) company, for Basilea's dermatology drug Toctino (alitretinoin) has been completed following antitrust approval and meeting other customary provisions.

Under the global agreement, Stiefel gains exclusive worldwide rights to Toctino as well as a license to know-how and assumes Basilea's existing distribution agreements for Toctino. Basilea receives an upfront payment of approximatelyCHF 225 million and will be eligible for a further milestone payment of up to GBP 50 million, related to a regulatory milestone of alitretinoin in the U.S.

In addition, Basilea will participate in future product sales in the U.S. through royalties starting three years after launch.

Click here to receive FREE breaking news email alerts for BASILEA PHARMACEUTIC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 152 Articles

Editors Pick

Adobe Profit Tops Estimate

Publishing and design software maker Adobe Systems Inc. said Tuesday after the markets closed that its second quarter profit fell 66% from last year, hurt by lower revenue as well as higher costs and expenses. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations and its quarterly revenue was in line with analysts' forecast.

Stocks Show Strong Upward Move Ahead Of Fed Announcement - U.S. Commentary

Stocks showed a strong upward move over the course of the trading day on Tuesday, adding to the gains posted in the previous session. The rally came even as traders expressed some uncertainty ahead of tomorrow's Federal Reserve announcement. The major averages gave back some ground going into the close but remained firmly in positive territory.

Boehner Indicates Immigration Bill Must Have Majority GOP Support

In a potential roadblock to comprehensive immigration reform legislation, House Speaker John Boehner, R-Ohio, indicated Tuesday that he would not bring a bill to the floor unless it is supported by a majority of House Republicans.